$AXGN news
The latest AXGN stock news: headlines, filings, AI summaries and sentiment for $AXGN, updated around the clock.
- Axogen, Inc. - 8-K Filing
- Axogen, Inc. - 10-Q Filing
- Axogen Reports Strong Q3 2026 Growth Driven by Avance Nerve Graft Demand
- Axogen Reports 26% Revenue Growth in Q3 and Forecasts $290 Million for 2026
- Axogen, Inc. - 8-K Filing
- Axogen, Inc. - 8-K Filing
- Axogen Acquires BioCircuit for $200 Million to Expand Sutureless Nerve Repair Technology
- Axogen Acquires BioCircuit for $200M to Expand Nerve Repair Portfolio
- Axogen, Inc. - 8-K Filing
- Axogen, Inc. - 8-K Filing
- AxoGen Reports Mixed Q2 Results; Updates FY26 Outlook
- Axogen, Inc. - 8-K Filing
- Neuronetics Appoints New Chief Financial Officer
- Axogen Forecasts At Least $270M in 2026 Revenue with 20% Growth Amid Avance Biologic Transition
- Axogen Reports Q1 2025 Earnings with Revenue Growth and Improved Adjusted EBITDA
- Axogen Reports Q3 2025 Earnings with Revenue Growth and Improved Margins
- AxoGen Reports Strong Q1 2026 Revenue Growth and Raises Full-Year Guidance
- AxoGen Reports Q1 Non-GAAP EPS of $0.07 and Revenue of $61.46M
- Capricorn Fund Invests $22.4 Million in Axogen (AXGN) for Nerve Repair Technology
- Capricorn Fund Invests $22.4 Million in Axogen (AXGN) Shares
- Axogen Reports Q2 2025 Earnings with Revenue Growth and Improved Profitability